HCWB HCW Biologics Inc.
Price Chart
Executive Summary
HCW Biologics priced a private placement of ~2.85M units at $1.405/unit, raising ~$4M in gross proceeds. The offering includes common stock (or pre-funded warrants) and warrants, significantly diluting existing shareholders.
Key Financial Metrics
Actionable Insight
The dilutive offering will likely weigh on the stock near term. Watch for the stock's reaction at closing; the warrants add overhang but the cash provides runway for clinical trials.
Key Facts
- 2,846,975 units at $1.405 per unit for ~$4M gross proceeds
- Each unit consists of one share of common stock (or pre-funded warrant) and one warrant to purchase one share at $1.28
- Warrants exercisable immediately, expire in 5.5 years
- Proceeds used for clinical trials (HCW9302), IND-enabling studies (HCW11-018b, HCW11-040), and general corporate purposes
- E.F. Hutton acting as sole placement agent
- Market cap ~$16M, offering represents ~25% dilution from shares alone
Financial Impact
Gross proceeds of ~$4M, representing ~25% dilution based on current market cap of $16M; additional dilution possible from warrant exercise.
Risk Factors
- Immediate dilution from new shares and pre-funded warrants
- Warrant overhang with potential future dilution
- Execution risk in clinical programs
- Stock price pressure from increased supply
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3299462 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
5d ago
|
8-K
| $2.07 $1.79 | ▲ +13.53% | ▲ +13.67% | $1.63 (+21.26%) |
|
May 27, 2026
10d ago
|
Insider Cluster
| $2.09 $1.98 | ▼ −5.26% | ▼ −5.50% | $1.63 (−22.01%) |
|
May 27, 2026
10d ago
|
8-K
| $1.94 $2.09 | ▲ +7.73% | ▲ +7.18% | $1.63 (−15.98%) |
|
May 21, 2026
16d ago
|
8-K
| $2.89 $2.62 | ▲ +9.34% | ▲ +9.93% | $1.63 (+43.60%) |
|
May 21, 2026
16d ago
|
Press Release
| $2.58 $2.89 | ▼ −12.02% | ▼ −11.57% | $1.63 (+36.82%) |
|
May 14, 2026
23d ago
|
8-K
| — | awaiting T+1 | — | — |
|
May 14, 2026
23d ago
|
Press Release
| — | awaiting T+1 | — | — |
|
May 14, 2026
23d ago
|
Press Release
| $0.3370 $1.22 | ▲ +262.02% | ▲ +263.24% | $1.63 (+383.68%) |
|
Apr 30, 2026
5w ago
|
8-K
| — | awaiting T+1 | — | — |
|
Apr 24, 2026
6w ago
|
S-1/A
| $0.4390 $0.4000 | ▼ −8.88% | ▼ −8.40% | $1.63 (+271.30%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access